These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6144572

  • 1. Solubilization in high yield of opioid receptors retaining high-affinity delta, mu and kappa binding sites.
    Demoliou-Mason CD, Barnard EA.
    FEBS Lett; 1984 May 21; 170(2):378-82. PubMed ID: 6144572
    [Abstract] [Full Text] [Related]

  • 2. Characterization of opioid receptor subtypes in solution.
    Demoliou-Mason CD, Barnard EA.
    J Neurochem; 1986 Apr 21; 46(4):1129-36. PubMed ID: 2869106
    [Abstract] [Full Text] [Related]

  • 3. Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites.
    Itzhak Y, Hiller JM, Gioannini TL, Simon EJ.
    Brain Res; 1984 Jan 23; 291(2):309-15. PubMed ID: 6320961
    [Abstract] [Full Text] [Related]

  • 4. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ, Green IC, Thorpe JR, Titheradge MA.
    Biochem J; 1990 Apr 01; 267(1):233-40. PubMed ID: 1970240
    [Abstract] [Full Text] [Related]

  • 5. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J, Benyhe S, Hepp J, Khan A, Borsodi A, Szücs M, Medzihradszky K, Wollemann M.
    Neuropeptides; 1987 Jul 01; 10(1):19-28. PubMed ID: 2890119
    [Abstract] [Full Text] [Related]

  • 6. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep 01; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 7. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug 01; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 8. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 01; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 9. Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain.
    Simon J, Szücs M, Benyhe S, Borsodi A, Zeman P, Wollemann M.
    J Neurochem; 1984 Oct 01; 43(4):957-63. PubMed ID: 6088699
    [Abstract] [Full Text] [Related]

  • 10. ADP-ribosylation with pertussis toxin modulates the GTP-sensitive opioid ligand binding in digitonin-soluble extracts of rat brain membranes.
    Wong YH, Demoliou-Mason CD, Barnard EA.
    J Neurochem; 1988 Jul 01; 51(1):114-21. PubMed ID: 2837532
    [Abstract] [Full Text] [Related]

  • 11. Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors.
    Itzhak Y, Hiller JM, Simon EJ.
    Proc Natl Acad Sci U S A; 1984 Jul 01; 81(13):4217-21. PubMed ID: 6330751
    [Abstract] [Full Text] [Related]

  • 12. Purification of opioid-binding materials from rat brain.
    Fujioka T, Inoue F, Kuriyama M.
    Biochem Biophys Res Commun; 1985 Sep 16; 131(2):640-6. PubMed ID: 2996518
    [Abstract] [Full Text] [Related]

  • 13. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug 16; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 14. The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum.
    Crema G, Gioannini TL, Hiller JM, Simon EJ.
    NIDA Res Monogr; 1986 Aug 16; 75():9-12. PubMed ID: 2829015
    [Abstract] [Full Text] [Related]

  • 15. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan 16; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 16. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ, Blanchard SG, Cuatrecasas P.
    Mol Pharmacol; 1984 Nov 16; 26(3):484-8. PubMed ID: 6149459
    [Abstract] [Full Text] [Related]

  • 17. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun 16; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

  • 18. Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography.
    Maneckjee R, Zukin RS, Archer S, Michael J, Osei-Gyimah P.
    Proc Natl Acad Sci U S A; 1985 Jan 16; 82(2):594-8. PubMed ID: 2982164
    [Abstract] [Full Text] [Related]

  • 19. Solubilization and characterization of kappa opioid binding sites from guinea pig cerebellum.
    Itzhak Y, Hiller JM, Simon EJ.
    Neuropeptides; 1984 Dec 16; 5(1-3):201-4. PubMed ID: 6099497
    [Abstract] [Full Text] [Related]

  • 20. Solubilization of high affinity corticotropin-releasing factor receptors from rat brain: characterization of an active digitonin-solubilized receptor complex.
    Grigoriadis DE, Zaczek R, Pearsall DM, De Souza EB.
    Endocrinology; 1989 Dec 16; 125(6):3068-77. PubMed ID: 2555137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.